The cost of medication non-adherence, versus the benefit of medication adherence, has been demonstrated in many studies during the past decade. In 2012, the Congressional Budget Office found that for every 1% increase in Medicare Part D prescriptions, there was a 0.2% decrease in Medicare Part A and B expenditures. With much of the available data showing benefit for adult users, researchers are now seeking to understand if this technology could also be impactful for children and adolescents. More specifically, could this technology help impact the affects noted and problems suffered from the opioid pandemic?